s6y
Company name or ticker
Search
Biomea Fusion, Inc.
4/A
A2A Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Thursday, April 6, 2023
Period
Mar 31, 2023
Accession number
0001859061-23-000003
Documents
PRIMARY DOCUMENT
4/A
On sec.gov
Filing index
All files
Complete submission text
SGML header